Company Overview of IBC Pharmaceuticals, L.L.C.
Key Executives for IBC Pharmaceuticals, L.L.C.
|There is no Key Executives data available.|
IBC Pharmaceuticals, L.L.C. Board Members*
|Name||Board Relationships||Primary Company||Age|
|David M. Goldenberg||8 Relationships||Immunomedics, Inc.||79|
|John Landis Ph.D.||2 Relationships||IBC Pharmaceuticals, L.L.C.||--|
|Henry N. Wagner Jr., M.D.||13 Relationships||IBC Pharmaceuticals, L.L.C.||--|
IBC Pharmaceuticals, L.L.C. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.